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Abstract
Access to efficient laboratory services is critical to patient care. Turnaround Time (TAT) is
one of the most important measures when judging the efficiency of any laboratory and care
system. Few studies on TAT exist for inpatient care settings within low- and middle-income
countries (LMICs).
Methods
We evaluated therapeutic TAT for a tertiary hospital in Western Kenya, using a time-motion
study focusing specifically on common hematology and biochemistry orders. The aim was
to determine significant bottlenecks in diagnostic testing processes at the institution.
Results
A total of 356 (155 hematology and 201 biochemistry) laboratory tests were fully tracked
from the time of ordering to availability of results to care providers. The total therapeutic TAT
for all tests was 21.5 ± 0.249 hours (95% CI). The therapeutic TAT for hematology was 20.3
± 0.331 hours (95% CI) while that for biochemistry tests was 22.2 ± 0.346 hours (95% CI).
Printing, sorting and dispatch of the printed results emerged as the most significant bottle-
necks, accounting for up to 8 hours of delay (Hematology—8.3 ± 1.29 hours (95% CI), Bio-
chemistry—8.5 ± 1.18 hours (95% CI)). Time of test orders affected TAT, with orders made
early in the morning and those in the afternoon experiencing the most delays in TAT.
Conclusion
Significant inefficiencies exist at multiple steps in the turnaround times for routine laboratory
tests at a large referral hospital within an LMIC setting. Multiple opportunities exist to improve
TAT and streamline processes around diagnostic testing in this and other similar settings.
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Introduction
A functional and accessible clinical laboratory infrastructure plays a crucial role in determining
the diagnosis and treatment of communicable and non-communicable diseases alike. [1] Liter-
ature has shown the importance of clinical laboratories in facilitating clinical decision-making
processes in a range of clinical diseases. [2–4] Inadequate access to quality-assured laboratory
results often leads to further wastage of limited resources and potential harm to patients. [5]
Access to well-equipped diagnostic testing is limited in low- and middle-income countries
(LMICs), especially in Sub-Saharan Africa (SSA). [6, 7] Barriers to reliable laboratory testing
include: inadequate health-care infrastructure to support laboratory capacity, poor quality of
laboratory facilities, low availability of equipment and supplies, lack of implementation of stan-
dardized operating procedures, and lack of adequate personnel. Without diagnostic testing sup-
port, misdiagnosis (i.e. under- or over-diagnosis) based on clinical signs and symptoms occur
frequently. [7] While improving access to diagnostic equipment and laboratory resources repre-
sents a crucial step to improving health outcomes in LMICs, other opportunities exist to ensure
that quality diagnostic testing is done in a timely, cost-effective and efficient manner. [8, 9]
An opportunity to improve diagnostic testing relies on identification of laboratory work-
flow to identify bottlenecks in turnaround time (TAT). Workflow evaluation helps in rethink-
ing of processes and can help clinical laboratories do more with less. [10] Improving workflow
efficiency in the laboratory is a cost-effective approach to maximizing health benefits for
patients despite limited resources being available. [10] Quality improvement efforts geared
towards improving the workflow have shown improved efficiency in hospital care settings
within LMICs. [11–13] Human error, communication system breakdowns, redundant work
steps and slow TAT all contribute to reduced workflow efficiency. [14] Redundant steps in the
laboratory testing workflow are particularly common in LMIC settings, which commonly use
paper-based laboratory service requests and results reporting. Such redundancies include fill-
ing entry and exit logs, and signing in and out samples and laboratory results. Lost paper
requests and laboratory reports often mean another set of documentation. All these deficien-
cies further increase the TAT for results, with poor health consequences downstream. [15–17]
Quality has been defined as the ability of a service or product to satisfy the needs of a cus-
tomer. [18] Clinical laboratories have traditionally focused on imprecision and inaccuracy to
define the quality of results. This is a restrictive definition that focuses only on the technical
aspect. Comprehensive laboratory result quality to the clinician encompasses precision, accu-
racy, availability, cost, relevance and timeliness. [19] Timeliness is considered to be one of the
most crucial measures as it has a significant impact on patient care and satisfaction. It is for
this reason that we are seeing increased use of point of care (POC) testing instruments. [19]
Timeliness for diagnostic testing is commonly measured using the TAT.
To various stakeholders, TAT is often variably defined. However, for care providers who
order the tests, TAT has most relevance in its definition as the time from the ordering of the
test to the time when the result is available to the clinician. Delays relating to pre and post ana-
lytic phases are estimated to be responsible for up to 96% of total TAT, and a simple intra-labo-
ratory definition of TAT risks grossly underestimating clinically-relevant TAT. [20]
Lundberg first outlined the activities involved in the performance of a laboratory test as a
series of nine steps, namely: ordering, collection, identification, transportation, preparation,
analysis, reporting, interpretation and action. [21] He defined the TAT that involves all the
nine steps as the brain to brain TAT or the “therapeutic TAT”. [21] The therapeutic TAT is
the most comprehensive measure of timeliness of a clinical laboratory.
In LMICs like in other settings, many tests are ordered with need for timely access to results
to help with critical care decisions. The aim of this study was to measure the therapeutic TAT
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for common hematological and biochemical analyses at a national referral hospital and to
identify processes and factors that contribute most to delays in TAT.
Methods
Setting
This was a prospective, descriptive, single-center study of therapeutic TAT for common labo-
ratory tests at a tertiary hospital in Kenya. The hospital has achieved ISO accreditation in Qual-
ity Management Systems (ISO 9001:2015 Standard) and Medical Laboratory Standard (ISO
15189:2012 Standard). The study took place at the adult medicine wards of the hospital. The
hospital has 11 clinical laboratories, namely: hematology, biochemistry, microbiology, tuber-
culosis, immunology, histology/pathology, parasitology, blood bank, blood transfusion unit,
private wing and children’s unit. The laboratories operate 24/7 and testing is run continuously
although samples are received in batches. There are no point of care tests done at the hematol-
ogy and biochemistry laboratories although some point of care tests occur at the wards e.g.
random blood sugar tests. These point of care tests were excluded from this study. None of the
laboratories had a laboratory information system (LIS) at the time of the study. The laborato-
ries operate daily with a total of 6 pathologists (1 full-time and 5 part-time) and 146 laboratory
technologists under employment.
Quantifying turnaround time
The Lundberg definition of TAT was used in this paper. [21] This means that the pre-analytical
TAT used was from the point of order of tests to the receipt of samples at the laboratory. Simi-
larly, the post-analytic phase started from the time results were available at the laboratory to
the point where clinicians could access it for action. The Therapuetic TAT was quantified
using a time motion analysis approach. During the study period, a trained research assistant
(RAs) rounded daily with the Inpatient ward team, and followed the relevant laboratory tests
ordered throughout all processing steps over a 24-hour period. Over a seven-week period, RAs
tracked the two most commonly ordered tests, namely full hemogram (FHG) hematology
tests and the Urea, Electrolyte and Creatinine (UEC) biochemistry tests—hematology and
biochemistry tests are used subsequently to describe these tests in this paper. The first week of
data collection was discarded to compensate for the Hawthorne effect, as clinician or labora-
tory staff behavior might change when they were initially being observed. [22] Standardized
data collection forms were developed for data entry using REDCap tool (Figs 1–4), and these
were loaded onto mobile devices for use by the RAs. During rounds, the RAs equipped with a
mobile device with the REDCap data collection tool, recorded the time of test order, and then
followed those tests throughout the laboratory workflow process, assigning a time stamp at
each of the steps outlined below (Fig 5). The RAs also collected relevant laboratory time-
stamps from the laboratory computers system, as time-stamps were generated when the labo-
ratory test was both analyzed and when the results were printed.
In addition to laboratory workflow time-stamp data, we also collected other data to help in
further evaluating the TAT times observed. These additional data collected included: number
of clinicians, laboratory personnel, nurses and phlebotomists present at the time each labora-
tory test was being tracked. We also documented challenges noted by RAs during tracking of
laboratory tests using a standardized coded list of items. Coded list of challenges included: (1)
Misplaced laboratory order inaccessible to phlebotomist, (2) Patient declined sample to be
taken, (3) Patient unavailable for sample collection, (4) Sample collected but misplaced before
leaving the ward, (5) Sample left ward but was not received in the laboratory, (6) Sample was
clotted, (7) Sample volume was insufficient for analysis, (8) Sample received in laboratory but
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misplaced, (9) Analysis was done but result was not printed, and (10) Result printed but then
misplaced.
Patient-level data with patient-identifiers were also collected temporarily to track the TAT
of labs during a 24-hour period. The RAs needed to collect the patient’s name, identification
number, and location on the ward in order to locate the patient’s laboratory test. These patient-
level data were stored securely on a password-protected device. At the end of each 24-hour
period, the patient-level data and protected health information were permanently destroyed.
The study was approved by the Institutional Review and Ethics Committee at Moi University.
Sample size determination
For tests with long TAT as was expected in the setting of this study, sample sizes between 100
and 500 are recommended in order to give reproducible means for TAT. Given that the
Fig 1. Laboratory workflow process. The figure shows the complete brain to brain workflow processes involved
between the order of the common laboratory tests and the availability of the results to clinicians.
https://doi.org/10.1371/journal.pone.0230858.g001
Fig 2. Tests per time. The figure shows the number of tests done per time of the day.
https://doi.org/10.1371/journal.pone.0230858.g002
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Fig 3. TAT for time of order. The box-plot shows the time the test was ordered and impact on TAT.
https://doi.org/10.1371/journal.pone.0230858.g003
Fig 4. TAT for day of order. The box-plot shows the day of the week when the test was ordered and impact on TAT.
https://doi.org/10.1371/journal.pone.0230858.g004
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inpatient units chosen for this study typically sent orders for around 15 to 20 samples each of
hematology or biochemistry tests per day, we chose a consecutive sampling approach. [14]
Data analysis
The collected study data were extracted from the REDCap database and patient identifying
information were removed as outlined above. Study personnel scanned these data for any
inconsistencies in timestamps recorded, missing or invalid timestamps. The data were trans-
ferred to Microsoft Excel spreadsheets, with one spreadsheet each for hematology and bio-
chemistry tests. The timestamps were then separated in columns in keeping with the
Lundbergs nine-step workflow as shown in (Fig 5). [21] For each laboratory test record, time
difference between one step and the subsequent step was calculated and recorded. For each
time difference for every step, three calculations of TAT were done: Mean, Median and 90%
completion time. These three measures are among four recommended by Steindel and Novis
as being adequate and comprehensive measures of TAT. [23]
Given the long therapeutic TAT, the mean was used primarily as it is regarded to be a more
objective measure in long TAT. This is based on a recommendation by Hawkins et al. [14]
Boxplots were used to show the relationships of the TAT and the number of personnel present
during the workflow process.
Results
Overall
A total of 460 laboratory tests (200 hematology and 260 biochemistry) belonging to 239 unique
patients were tracked during a seven-week period between July and September 2018. To mini-
mize the Hawthorne effect, the 42 laboratory tests that were tracked in the first week of the
study were not included in the final analysis. Of the remaining 418 (180 hematology and 238
biochemistry) laboratory tests that were tracked, 62 (13.5%) were not fully processed and these
included 26 (5.7%) hematology and 36, (7.8%) biochemistry), with the results never making it
Fig 5. Number of doctors and impact on TAT. The box-plot shows the number of doctors present when the test was
ordered and impact on TAT.
https://doi.org/10.1371/journal.pone.0230858.g005
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back to the clinical team that ordered the test. Reasons leading to non-completion of the tests
are outlined in Table 1.
Therapeutic TAT
The remaining 356 out of 418 tests (85.2%), made of 155 hematology and 201 electrolyte tests,
went through the whole work-flow process. Table 2 summarizes the therapeutic TAT for hema-
tology and electrolyte tests. The average therapeutic TAT for hematology was 20.3 ± 0.331
hours (95% CI) while that for biochemistry was 22.2 ± 0.346 hours (95% CI). The processing
step that caused the biggest delay in TAT was ‘Printing, sorting and dispatch’ of results. The
mean time taken by this step for hematology and biochemistry was 8.3 ± 1.29 hours (95% CI)
and 8.5 ± 1.18 hours (95% CI) respectively. In both cases, the distribution was heavily skewed
to the left resulting in the large standard deviation observed. Transportation of samples was the
most efficient process with the mean transportation time for both hematology and biochemis-
try tests being around 10 minutes. Analysis took significantly longer with biochemistry when
compared with hematology, which was the primary contributor to the significantly longer TAT
overall for biochemistry compared with hematology tests (Table 2).
A majority of orders were done between 9:30am and 12:00pm with a peak at 10:30am (Fig
6). Orders done during peak times experienced the longest TAT (Fig 7). Orders done in the
morning hours (up to 11am) experienced longer TAT when compared with orders done after
12pm (Fig 7).
There was a variation in the TAT based on the day of the week in which orders were made
(Fig 8). Orders for tests done later in the week had longer TAT. There was no apparent rela-
tionship between the number of personnel present during the workflow process and the thera-
peutic TAT (Fig 9). However, it emerged that the more personnel were present, the longer the
TAT (Fig 10). The more the number of orders, the more the number of personnel that were
deployed to process the orders as well.
Discussion
In essence, our study demonstrated that test results that had been analysed and were available
for care could not be accessed by clinicians for another 18 hours. Our findings further add to
the evidence that pre-analytical and post-analytical phases of laboratory processing contribute
up to 96% of total TAT. [24]
Table 1. List of tests misplaced in the workflow.
Reason for the test not getting to the clinician Hematology Biochemistry Total
# # # (% of Total)
Misplaced laboratory order inaccessible to phelobotomist 3 4 7 (1.5)
Patient declined sample to be taken 0 1 1 (0.2)
Patient unavailable for sample collection 4 3 7 (1.5)
Sample collected but misplaced before leaving the ward 2 5 7 (1.5)
Sample left ward but was not received in the laboratory 4 6 19 (4.1)
Sample was clotted 3 2 2 (0.4)
Sample volume was insufficient for analysis 0 1 1 (0.2)
Sample received in laboratory then misplaced 2 2 4 (0.9)
Analysis was done but result was not printed 5 5 10 (2.2)
Result printed but then misplaced 3 7 10 (2.2)
Total 26 36 62 (13.5)
https://doi.org/10.1371/journal.pone.0230858.t001
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Steindel and Novis identified four measures that can be used to adequately represent TAT.
[23] These are the mean, median, 90th percentile and proportion of acceptable tests or outliers.
In this study we used a combination of the mean, median and the 90th percentile in order to
capture a comprehensive picture of TAT (Table 2).
Consolidated data available through external quality control programs like the CAP robes
and Q-Track remain the reference point for laboratory TAT. A 2001 Q-Probes study con-
cluded that the optimal time from order to reporting for biochemistry tests was 47 minutes
while that for hematology was 35 minutes. [25] While comparisons with other studies is diffi-
cult because of varied definitions of TAT, it is still clear that the TAT in our study was signifi-
cantly prolonged compared to recommended TAT for the tracked tests.
A time motion study done at the John Radcliffe Hospital (JRH), Oxford, UK in comparison
determine that the TAT for hematology results was 1 hour 6 minutes (95% CI: 29 minutes to 2
hours 13 minutes) and that for biochemistry was 1 hour 42 minutes (95% CI: 1 hour 1 minute
to 4 hours 21 minutes). [26] This was in a setting where result were immediately available to
Table 2. Turnaround time for specific time intervals of the workflow process.
Hematology Biochemistry
Mean Median 90th Perc Mean Median 90th Perc p-value
Hrs (SD) Hrs Hrs Hrs (SD) Hrs Hrs (Mean)
Order to Sample collection 2.18 (2.2) 2.08 3.3 2.1 (1.2) 2.15 3.24 0.6616
Sample collection to transport 1.24 (0.7) 1.16 2.19 1.25 (0.7) 1.17 2.17 0.8938
Transport to received in laboratory 0.15 (0.2) 0.08 0.42 0.16 (0.3) 0.1 0.42 0.7205
Pre-analytic period 0.71 (0.5) 0.63 1.24 0.72 (1.6) 0.5 1.22 0.9402
Analysis 1.06 (2.1) 0.85 1.73 2.06 (2.5) 1.55 3.17 0:0001
Printing sorting and dispatch 8.25 (8.2) 2.33 17.36 8.47 (7.9) 2.55 16.25 0.7979
Transport to received in the ward 2.30 (5.4) 0.22 15.07 2.07(6.3) 0.17 9.87 0.7167
Received in ward to access by clinician 7.99 (8.0) 1.67 16.17 7.46 (8.8) 1 16.2 0.5583
Overall turnaround Time 20.3 (2.1) 9.02 22.2 (2.5) 9.19 0:0001
https://doi.org/10.1371/journal.pone.0230858.t002
Fig 6. TAT for time of order. The box-plot shows the number of laboratory personnel present when the test was
processed and impact on TAT.
https://doi.org/10.1371/journal.pone.0230858.g006
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Fig 7. Ward to laboratory order instrument. Instrument used to record initial laboratory order.
https://doi.org/10.1371/journal.pone.0230858.g007
Fig 8. Sample collection instrument. Instrument used to record data during sample collection.
https://doi.org/10.1371/journal.pone.0230858.g008
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Fig 9. Intra laboratory instrument. Instrument used to record data during the analytical stage.
https://doi.org/10.1371/journal.pone.0230858.g009
Fig 10. Post laboratory instrument. Instrument used to record data during the post analytical phase.
https://doi.org/10.1371/journal.pone.0230858.g010
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clinicians after analysis through electronic medical record systems. These and other observa-
tions demonstrate the importance of automating laboratory result delivery process, a step that
was missing in our study setting as all steps were manual and paper-based.
In our study setting, printed results were batched for as long as 8.2 hours and 7.9 hours for
CBC and UECs respectively. Printing and paper result delivery is not necessary in setups
where computerized provider order entry (CPOE), laboratory information systems (LIS) and
electronic medical record (EMR) systems have been implemented. Studies have shown that
EMR and CPOE systems reduces both intra-laboratory and total TAT. [27] The impact of
CPOE in our setting will probably be more significant given that up to 30% of analyzed results
got misplaced—with half of the misplaced results being those that were analyzed but not
printed, while the other half were printed and the paper result were untraceable.
Steindel and Novis suggest that 30 minutes as a reasonable time pre-analytic time, within
which laboratory results should be received and verified. [23] In our study, for both hematol-
ogy and biochemistry tests, the pre-analytic period lasted more than 30 minutes. This long
pre-analytic time was partly a result of the manual recording processes needed to detail
ordered tests in a paper register before being verified and received for processing.
Batching of the orders, of the collected samples and of results also contributed to the long
overall TAT. Orders made early in the morning had a longer TAT as they were batched and
had to wait for all orders before phlebotomy began (Fig 7). Orders done later in the day missed
the batch and sometime could not get to the laboratory in time for analysis with the days’ ear-
lier batch. Pneumatic transportation systems eliminate the need for batching and ensure
consistently low TAT regardless of the time of order. [28] In the study setting, pneumatic
transport systems, and use of point of care tests where relevant, could serve to reduce increased
TAT related to batching. [2, 9, 29]
It was observed that orders done later in the week took significantly longer to process. This
may be associated with increased numbers of samples that needed to be processed as the week
progressed (Fig 8).
It surprisingly emerged that when more personnel were present during the processing of
orders, the overall TAT was longer (Figs 9 and 10). However, this could simply be a reflection
of the fact that more personnel are deployed in times of crisis or when the ward is busiest,
when TAT was already longer. This is an interesting finding that may need further exploration.
Limitations of our study include the fact that it was done within one referral hospital set-
ting that might not be reflecting of other clinical settings even within other LMICs. Further,
our assessment only involved hematology and biochemistry tests which were also all handled
within the facility. TAT will likely be different for other tests and for send out tests. However,
through this study, we provide a clear demonstration of the need to analyze TAT systemati-
cally within clinical settings in LMICs, and to implement mechanisms to mitigate long TAT.
Another limitation of the study is that it only considered printed laboratory results. In cases
where critical results were communicated either verbally or via text message, the study may
overestimate TAT. However the number of communicated critical results are low in this
setting.
There is need to streamline the steps involved in delivery of common laboratory results in
the tertiary hospital. As the next step, we hope to implement technology-based solutions to
help in quick processing of orders using computerized order entry approaches, and interfaces
that allow results to be availed immediately to providers. Such a solution will have to be tai-
lored for resource-limited settings that might have limited technological infrastructure and
financial resources. An approach that uses a mobile-based solution tethered to laboratory
information system could help address many of these challenges, and also help with timely
data collection to ensure real-time tracking of deficiencies in TAT.
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Conclusion
This time motion study in a tertiary hospital in Kenya demonstrated that there are significant
delays in delivery of hematology and biochemistry test results to clinicians in time. Despite
efficient analysis of results, the post analytic period contributed the most delay resulting in
more than 20 hours of therapeutic TAT. Printing, sorting and dispatch of results emerged as
the greatest bottleneck in the process. Transportation was the most efficient process but this
was in the context of batching of results before transport. There was a biphasic elongation of
TAT with early morning and afternoon orders bearing the most delay. The results of this study
elucidate specific bottlenecks and targets for interventions that could improve the efficiency of
the laboratory workflow process ultimately improving clinical care.
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